Immunoglobulin D-kappa multiple myeloma in a patient with rheumatoid arthritis: a case report and review of the literature. (2nd January 2021)

• Record Type: Journal Article
• Authors: Tokunaga, Tadahiro; Hashimoto, Hiroo; Yoshida, Yusuke; Sugimoto, Tomohiro; Mokuda, Sho; Kosaka, Yoko; Shimizu, Risa; Hirata, Shintaro; Kumagai, Tomoyo; Komoto, Kiichi; Wada, Hideho; Sugiyama, Eiji
• Is Part Of: Modern rheumatology case reports. Volume 5:Number 1(2021)
• Page Start: 22
• Page End: 28
• Publication Date: 2021-01-02
• Subjects: Immunoglobulin D multiple myeloma -- rheumatoid arthritis -- CRAB symptoms -- immunofixation -- methotrexate; Rheumatology -- Periodicals; 616.723005
• DOI: 10.1080/24725625.2020.1826651
• Languages: English
• ISSNs: 2472-5625

Abstract

Abstract: A 77-year-old Japanese woman with a 21-year history of seropositive, erosive rheumatoid arthritis (RA) and a 10-year history of methotrexate (MTX) therapy was admitted with malaise and mild consciousness disturbance. Laboratory data showed hypercalcemia, acute kidney injury, normocytic anaemia, and thrombocytopenia. As we first assumed drug-induced toxicity by MTX and eldecalcitol, both were discontinued and leucovorin rescue therapy and calcitonin were administered. However, her condition continued to worsen. Serum protein electrophoresis showed only a small M-peak, immunoelectrophoresis of both the serum and urine demonstrated Bence-Jones kappa (κ) type monoclonal protein without immunoglobulin heavy chain, and bone marrow examination revealed proliferation of plasma cells. We diagnosed her with Bence-Jones κ type multiple myeloma (MM) and transferred her to the department of haematology of a higher order medical institution. Conclusively, the diagnosis of immunoglobulin (Ig) D-κ type MM, a rare variant of this disorder, was determined in accordance with serum immunofixation. Several previous studies have suggested that pre-existing RA is a risk factor for MM. Although IgD MM is characterised by its clinical severity and poor prognosis compared to other subtypes, it is often misdiagnosed or mistaken as light chain type MM, as in the present case, because of the low level of IgD M-protein, resulting in delayed diagnosis. Physicians must take MM into consideration as a differential diagnosis when inactive RA patients present with inexplicable elevated calcium, renal failure, anaemia, and bone lesion symptoms and should be aware of IgD MM to establish the correct diagnosis promptly.